3-[4-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]-1,4-diazepane-1-carbonyl]pyrido[1,2-a]pyrimidin-4-one
C20H24N6O3 — CID 138808537
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[4-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]-1,4-diazepane-1-carbonyl]pyrido[1,2-a]pyrimidin-4-one
3-[4-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]-1,4-diazepane-1-carbonyl]pyrido[1,2-a]pyrimidin-4-one (PubChem CID 138808537) has the molecular formula C20H24N6O3 and a molecular weight of 396.45 g/mol. Its IUPAC name is 3-[4-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]-1,4-diazepane-1-carbonyl]pyrido[1,2-a]pyrimidin-4-one.
Molecular Properties
| Compound Name | 3-[4-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]-1,4-diazepane-1-carbonyl]pyrido[1,2-a]pyrimidin-4-one |
|---|---|
| PubChem CID | 138808537 |
| Molecular Formula | C20H24N6O3 |
| Molecular Weight | 396.45 g/mol |
| Exact Mass | 396.19 |
| IUPAC Name | 3-[4-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]-1,4-diazepane-1-carbonyl]pyrido[1,2-a]pyrimidin-4-one |
| SMILES | CC(C)c1nc(CN2CCCN(C(=O)c3cnc4ccccn4c3=O)CC2)no1 |
| InChI | InChI=1S/C20H24N6O3/c1-14(2)18-22-16(23-29-18)13-24-7-5-8-25(11-10-24)19(27)15-12-21-17-6-3-4-9-26(17)20(15)28/h3-4,6,9,12,14H,5,7-8,10-11,13H2,1-2H3 |
| InChIKey | WMHDVNDYNUKACQ-UHFFFAOYSA-N |
| XLogP | 1.55 |
| TPSA | 96.84 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 396.45 |
| LogP ≤ 5 | 1.55 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138808537 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.